{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Nicotine Use Among Pregnant and Reproductive-Age Women: Epidemiology and Pharmacology - Part 1

Activity Steps

Description

NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.

Purpose of Activity

To provide information about nicotine use among pregnant and reproductive-age women.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Cite the prevalence of nicotine use among reproductive-age and pregnant women and identify populations at higher risk for nicotine use.
  2. Explain basic nicotine pharmacokinetics and pharmacodynamics.
  3. Describe how pregnancy can affect nicotine pharmacokinetics and pharmacodynamics.

Learning Outcomes

A majority of the participants will demonstrate knowledge of the effects of nicotine use in pregnant and reproductive age women by achieving a passing score on the post-test.
Price: $49.00

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: PGO1120A
Published: Nov 2020
Expires: 12/6/2024
Required Passing Score: 8/10 (80%)
Authors: Dennis J. Hand, PhD